secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2026-05-12T20:33:51+00:00
Accession:  0001628280-26-034149
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Q1 rev $9.6M (+3.1% YoY); net loss $1.4M; guides Q2 growth 10-15%
--------------------------------------------------------------------------

- Q1 revenue $9.6M, up 3.1% from $9.3M YoY; gross margin 77.3% vs 79.0%.
- GAAP operating loss $1.1M, a $1.7M swing from $0.6M operating income YoY.
- Ultramist consumables revenue $6.7M, up 15% YoY; set new all-time unit volume record.
- Adjusted EBITDA $1.1M vs $2.3M YoY; net loss $1.4M, improved from $6.1M loss (prior year had $4.9M non-cash derivative loss).
- Guides Q2 2026 revenue $11.1-11.6M (10-15% growth); reaffirms FY 2026 revenue $51-55M (16-25% growth).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/0001628280-26-034149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/snwv-20260512.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-034149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer